Sulindac | List of Frontiers open access articles

Original Research

Published on 30 Apr 2025

Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Shuning Chen
Weimin Kong
Xiaochang Shen
Nikita Sinha
Jennifer Haag
Boer Deng
Haomeng Zhang
Catherine John
Wenchuan Sun
Chunxiao Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1520771

2,585 views
1 citation

Original Research

Accepted on 16 Feb 2026

Machine Learning-Based QSAR and Molecular Modeling of Phytocompounds in Barleria buxifolia L. as a Potential Aldose Reductase Inhibitor

in Drug Discovery in Bioinformatics

Radul R. Dev
Anjana C. Lalu
Sinana Zarin
Bristow Ben Joseph
Rajesh Raju
Abhithaj J
Sangeeth Thekkan

Frontiers in Bioinformatics

Original Research

Published on 24 Apr 2020

Integrating Genome-Wide Association Studies and Gene Expression Profiles With Chemical-Genes Interaction Networks to Identify Chemicals Associated With Colorectal Cancer

in Computational Genomics

Xinyue Tan
Hanmin Tang
Liuyun Gong
Lina Xie
Yutiantian Lei
Zhenzhen Luo
Chenchen He
Jinlu Ma
Suxia Han

Frontiers in Genetics

doi 10.3389/fgene.2020.00385

7,827 views
8 citations

Original Research

Published on 30 Jun 2021

Computational Drug Repurposing for Alzheimer’s Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies

in Translational Pharmacology

Yun Xu
Jiming Kong
Pingzhao Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.617537

18,333 views
36 citations

Original Research

Published on 13 Oct 2023

Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Fokhrul Hossain
Deniz A. Ucar
Giulia Monticone
Yong Ran
Samarpan Majumder
Kristina Larter
Hanh Luu
Dorota Wyczechowska
Soroor Heidari
Keli Xu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1244159

6,022 views
13 citations

Systematic Review

Published on 15 Nov 2023

Eflornithine for chemoprevention in the high-risk population of colorectal cancer: a systematic review and meta-analysis with trial sequential analysis

in Gastrointestinal Cancers: Colorectal Cancer

Lifeng Yang
Yan Wang
Shasha Hu
Xiaoyan Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1281844

3,125 views
7 citations

Original Research

Published on 24 May 2023

Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey

in Gastrointestinal Cancers: Colorectal Cancer

Kathryn A. Mraz
Rachel Hodan
Linda Rodgers-Fouche
Sanjeevani Arora
Francesc Balaguer
Jose G. Guillem
Joanne M. Jeter
Priyanka Kanth
Dan Li
David Liska

Frontiers in Oncology

doi 10.3389/fonc.2023.1141810

5,475 views
9 citations

Articles

Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer

Machine Learning-Based QSAR and Molecular Modeling of Phytocompounds in Barleria buxifolia L. as a Potential Aldose Reductase Inhibitor

Integrating Genome-Wide Association Studies and Gene Expression Profiles With Chemical-Genes Interaction Networks to Identify Chemicals Associated With Colorectal Cancer

Computational Drug Repurposing for Alzheimer’s Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies

Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer

Eflornithine for chemoprevention in the high-risk population of colorectal cancer: a systematic review and meta-analysis with trial sequential analysis

Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey